Related Experiment Video

Updated: May 10, 2026

Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay
05:21

Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay

Published on: September 13, 2024

[Influence of BRAF interference on SW579 cell lines in thyroid cancer]

Wenjun Yi1, Dewu Zhong, Qiongyan Zou

  • 1Department of General Surgery, Central South University, Changsha, China. yiwenjun@csco.org.cn

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|July 6, 2013
PubMed
Abstract

Insights

Targeting BRAF (v-raf murine sarcoma viral oncogene homolog B1) with siRNA inhibited SW579 thyroid cancer cell growth and proliferation. This BRAF interference also deactivated the MEK/ERK signaling pathway.

Area of Science:

  • Molecular biology
  • Cancer research
  • Signal transduction

Context:

  • Thyroid cancer is a significant health concern.
  • SW579 cell line is a relevant model for thyroid cancer research.
  • The BRAF oncogene plays a role in cancer development.

Purpose:

  • To investigate the effect of BRAF interference on SW579 cells.
  • To explore the impact of BRAF inhibition on cell proliferation and cell cycle.
  • To determine the influence of BRAF on the MEK/ERK signaling pathway.

Summary:

  • RNA interference (siRNA) targeting BRAF (v-raf murine sarcoma viral oncogene homolog B1) was successfully implemented in SW579 thyroid cancer cells.
  • BRAF mRNA and protein expression were significantly reduced, leading to inhibited cell proliferation and altered cell cycle progression (increased G1/S phase).
  • The MEK/ERK signaling pathway was also inhibited following BRAF interference.

Impact:

  • BRAF inhibition demonstrates potential as a therapeutic strategy for thyroid cancer.
  • Understanding BRAF's role in the MEK/ERK pathway provides insights into cancer mechanisms.
  • This study contributes to the development of targeted therapies for thyroid cancer.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...